GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

Findings provide early evidence supporting potential disease-modifying activity of AP01 (inhaled pirfenidone) in patients ...

BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases ...

A woman was convicted of delivering a fatal buttocks injection during an unlicensed cosmetic procedure at a Burlingame hotel, ...

The newly added medicines include two for type 2 diabetes, Jentadueto and Jentadueto XR, and one for chronic obstructive ...

Background Patients with single ventricles after bidirectional Glenn (BDG) are placed on ACE inhibitors (ACEIs) to reduce ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Among extrapulmonary cases, lymph node tuberculosis is the most frequently reported. It typically presents as painless ...

Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these ...

AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with ...

The tool is the most accurate prognostic score of its kind and has the potential to improve COPD patient care whilst easing pressure on the NHS.

Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug ...